BEIJING (Reuters) – A bearish commentary by a prominent economist on China’s weak consumption, unemployment and “dispirited” youth that went viral on…
(Reuters) – Futures linked to Wall Street’s main indexes were largely flat on Friday, with investors cautious ahead of a monthly jobs…
By Stefano Rebaudo (Reuters) – French debt risk premiums versus safe-haven German Bunds fell on Friday, after French President Emmanuel Macron said…
(Reuters) – Global equity funds saw a notable rise in inflows in the week through Dec. 4, driven by a record-setting rally…
Neuralink, the brain technology firm led by Elon Musk, has been cited by the Food and Drug Administration (FDA) for “objectionable conditions…
By Maria Martinez BERLIN (Reuters) – For Eva Henschke, Germany’s Christmas markets are a chance to temporarily forget about the colder, darker…
PARIS (Reuters) – The fall of the government leaves France without a clear path toward reducing its budgetary deficit, credit rating agency…
By Promit Mukherjee OTTAWA (Reuters) – Canada’s fiscal targets over the next few years will be tougher to achieve as a promised…
By Rachael Levy (Reuters) – An animal testing laboratory at Elon Musk’s Neuralink brain technology company was found to have “objectionable conditions…
By Howard Schneider WASHINGTON (Reuters) – In another era, agreement among analysts from leading left, center, and right-leaning think tanks over a…
